山东威高集团医用高分子制品股份有限公司（股票代码：01066）于2026年4月16日发布公告，称当日于香港联交所场内回购股份共计20万股，占公司该日股份变动前已发行股本约0.0045%。
回购价格介乎每股3.63港元至3.67港元，总涉资约73万港元。回购完成后，公司已发行股份数变更为4,470,846,724股，库藏股增至51,485,600股。
公司购回授权于2025年5月27日通过，可回购股份总数为451,560,392股。截至公告日，累计回购44,837,200股，占授权通过时公司已发行股本约9.9294%。公司确认已遵守香港联交所证券上市规则及相关法律法规。
本次公告由公司秘书黄妙玲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.